Annexin A6, transported in the extracellular vesicles of cancer-associated fibroblasts (CAFs), promotes drug resistance in a mouse metastatic tumor model by mediating the activation of FAK/YAP pathway in cancer cells via integrin β1 (Uchihara et al., 2020). Here, ANXA6 is linked to cancer.